Weighing the Effects of Immunosuppression for Hyperinflammation in COVID-19
The effects of reducing hyperinflammation by immunosuppression has been discussed in this editorial.
The effects of reducing hyperinflammation by immunosuppression has been discussed in this editorial.
Researchers evaluated the effect of biologics and glucocorticoids on outcomes after major surgeries in rheumatoid arthritis.
Prospective, observational study assessed 4 treatment protocols and their effects on skin thickening.
Results confirm that low baseline hepatitis B surface antibody titers are significant risk factors for HBV reactivation in patients with rheumatoid arthritis.
The estimated prevalence of current immunosuppression is 2.7% among the US population.